{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:44:43Z","timestamp":1792115083528,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jaci.2026.04.027","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T17:57:58Z","timestamp":1779299878000},"page":"898-907","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-acting IL-7 restores T-cell reconstitution in a humanized mouse model of lymphopenia"],"prefix":"10.1016","volume":"158","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8948-554X","authenticated-orcid":false,"given":"Ainhoa","family":"P\u00e9rez-D\u00edez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangdong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashlynn","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marliece","family":"Barrios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra A.","family":"Wolfarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghoon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Lisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irini","family":"Sereti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2026.04.027_bib1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJM199302113280601","article-title":"Unexplained opportunistic infections and CD4+ T-lymphocytopenia without HIV infection. An investigation of cases in the United States. The Centers for Disease Control Idiopathic CD4+ T-lymphocytopenia Task Force","volume":"328","author":"Smith","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2026.04.027_bib2","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1182\/blood-2007-12-127878","article-title":"Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors","volume":"112","author":"Zonios","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2026.04.027_bib3","doi-asserted-by":"crossref","first-page":"5326","DOI":"10.1172\/JCI136254","article-title":"Prevalence and pathogenicity of autoantibodies in patients with idiopathic CD4 lymphopenia","volume":"130","author":"Perez-Diez","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2026.04.027_bib4","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1056\/NEJMoa2202348","article-title":"Reappraisal of idiopathic CD4 lymphocytopenia at 30 years","volume":"388","author":"Lisco","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2026.04.027_bib5","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.127802","article-title":"Humanized mouse models reveal an immunologic classification of idiopathic CD4 lymphocytopenia subtypes","volume":"4","author":"Perez-Diez","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaci.2026.04.027_bib6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1034\/j.1600-065X.2003.00050.x","article-title":"Death and Baxes: mechanisms of lymphotrophic cytokines","volume":"193","author":"Khaled","year":"2003","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jaci.2026.04.027_bib7","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nri2970","article-title":"Harnessing the biology of IL-7 for therapeutic application","volume":"11","author":"Mackall","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2026.04.027_bib8","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1182\/blood-2015-05-645077","article-title":"Administration of interleukin-7 increases CD4 T cells in idiopathic CD4 lymphocytopenia","volume":"127","author":"Sheikh","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2026.04.027_bib9","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.4049\/jimmunol.170.7.3528","article-title":"The MHC class I\u2013like IgG receptor controls perinatal IgG transport, IgG homeostasis, and fate of IgG-Fc\u2013coupled drugs","volume":"170","author":"Roopenian","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2026.04.027_bib10","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/cts.12800","article-title":"hIL-7-hyFc, a long-acting IL-7, increased absolute lymphocyte count in healthy subjects","volume":"13","author":"Lee","year":"2020","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.jaci.2026.04.027_bib11","doi-asserted-by":"crossref","first-page":"6093","DOI":"10.1182\/bloodadvances.2021006591","article-title":"A single administration of hIL-7\u2013hyFc induces long-lasting T-cell expansion with maintained effector functions","volume":"6","author":"Kim","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jaci.2026.04.027_bib12","article-title":"Phase I study of NT-I7, a long-acting interleukin-7, in severe treatment-related lymphopenia following standard radiation and temozolomide for high grade glioma","volume":"7","author":"Campian","year":"2025","journal-title":"Neurooncol Adv"},{"key":"10.1016\/j.jaci.2026.04.027_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-008989","article-title":"rhIL-7-hyFc, a long-acting interleukin-7, improves efficacy of CAR-T cell therapy in solid tumors","volume":"12","author":"Li","year":"2024","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.jaci.2026.04.027_bib14","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.immuni.2004.07.016","article-title":"Suppression of IL7Ralpha transcription by IL-7 and other prosurvival cytokines: a novel mechanism for maximizing IL-7\u2013dependent T cell survival","volume":"21","author":"Park","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2026.04.027_bib15","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1182\/blood-2009-10-246876","article-title":"IL-7 induces rapid clathrin-mediated internalization and JAK3-dependent degradation of IL-7Ralpha in T cells","volume":"115","author":"Henriques","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2026.04.027_bib16","doi-asserted-by":"crossref","first-page":"8732","DOI":"10.1073\/pnas.161126098","article-title":"IL-7 is critical for homeostatic proliferation and survival of naive T cells","volume":"98","author":"Tan","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2026.04.027_bib17","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1182\/blood.V97.6.1525","article-title":"Interleukin-7 restores immunity in athymic T-cell\u2013depleted hosts","volume":"97","author":"Fry","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2026.04.027_bib18","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/3877","article-title":"Defective IL7R expression in T\u2212B+NK+ severe combined immunodeficiency","volume":"20","author":"Puel","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaci.2026.04.027_bib19","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/80868","article-title":"Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo","volume":"1","author":"Schluns","year":"2000","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2026.04.027_bib20","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1146\/annurev.immunol.22.012703.104554","article-title":"Control of T cell viability","volume":"22","author":"Marrack","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaci.2026.04.027_bib21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/83381","article-title":"Increased production of IL-7 accompanies HIV-1\u2013mediated T-cell depletion: implications for T-cell homeostasis","volume":"7","author":"Napolitano","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2026.04.027_bib22","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1182\/blood-2006-06-031385","article-title":"Idiopathic CD4+ T lymphocytopenia is associated with increases in immature\/transitional B cells and serum levels of IL-7","volume":"109","author":"Malaspina","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2026.04.027_bib23","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1182\/blood-2010-12-323600","article-title":"Decreases in IL-7 levels during antiretroviral treatment of HIV infection suggest a primary mechanism of receptor-mediated clearance","volume":"118","author":"Hodge","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2026.04.027_bib24","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1093\/infdis\/jis219","article-title":"Decreased interleukin 7 responsiveness of T lymphocytes in patients with idiopathic CD4 lymphopenia","volume":"205","author":"Puronen","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaci.2026.04.027_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055570","article-title":"Altered responses to homeostatic cytokines in patients with idiopathic CD4 lymphocytopenia","volume":"8","author":"Bugault","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2026.04.027_bib26","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1182\/blood-2002-04-1082","article-title":"Interleukin 7 worsens graft-versus-host disease","volume":"100","author":"Sinha","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2026.04.027_bib27","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1158\/1078-0432.CCR-09-1303","article-title":"Phase I study of recombinant human interleukin-7 administration in subjects with refractory malignancy","volume":"16","author":"Sportes","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaci.2026.04.027_bib28","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1182\/blood.2023019721","article-title":"IL-7 receptor signaling drives human B-cell progenitor differentiation and expansion","volume":"142","author":"Kaiser","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2026.04.027_bib29","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jaut.2012.01.012","article-title":"IL-7 modulates B cells survival and activation by inducing BAFF and CD70 expression in T cells","volume":"38","author":"Sammicheli","year":"2012","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaci.2026.04.027_bib30","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jaci.2023.10.012","article-title":"Immune responses to SARS-CoV-2 mRNA vaccination in people with idiopathic CD4 lymphopenia","volume":"153","author":"Rocco","year":"2024","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674926003416?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674926003416?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:51:32Z","timestamp":1792111892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674926003416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0091674926003416"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2026.04.027","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-acting IL-7 restores T-cell reconstitution in a humanized mouse model of lymphopenia","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2026.04.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}